10-4995770-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_001393392.1(AKR1C2):āc.666T>Cā(p.His222=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00262 in 1,596,910 control chromosomes in the GnomAD database, including 85 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 0.018 ( 47 hom., cov: 27)
Exomes š: 0.0011 ( 38 hom. )
Consequence
AKR1C2
NM_001393392.1 synonymous
NM_001393392.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.51
Genes affected
AKR1C2 (HGNC:385): (aldo-keto reductase family 1 member C2) This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. These enzymes catalyze the conversion of aldehydes and ketones to their corresponding alcohols using NADH and/or NADPH as cofactors. The enzymes display overlapping but distinct substrate specificity. This enzyme binds bile acid with high affinity, and shows minimal 3-alpha-hydroxysteroid dehydrogenase activity. This gene shares high sequence identity with three other gene members and is clustered with those three genes at chromosome 10p15-p14. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 10-4995770-A-G is Benign according to our data. Variant chr10-4995770-A-G is described in ClinVar as [Benign]. Clinvar id is 805966.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0568 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AKR1C2 | NM_001393392.1 | c.666T>C | p.His222= | synonymous_variant | 6/9 | ENST00000380753.9 | |
LOC101928051 | XR_001747340.2 | upstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AKR1C2 | ENST00000380753.9 | c.666T>C | p.His222= | synonymous_variant | 6/9 | 1 | NM_001393392.1 | P1 | |
AKR1C2 | ENST00000421196.7 | c.588T>C | p.His196= | synonymous_variant | 5/8 | 1 | |||
ENST00000451575.6 | n.180+103A>G | intron_variant, non_coding_transcript_variant | 3 | ||||||
AKR1C2 | ENST00000460124.5 | n.2126T>C | non_coding_transcript_exon_variant | 5/8 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0176 AC: 2569AN: 146338Hom.: 44 Cov.: 27
GnomAD3 genomes
AF:
AC:
2569
AN:
146338
Hom.:
Cov.:
27
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000236 AC: 59AN: 250002Hom.: 1 AF XY: 0.000126 AC XY: 17AN XY: 135188
GnomAD3 exomes
AF:
AC:
59
AN:
250002
Hom.:
AF XY:
AC XY:
17
AN XY:
135188
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00111 AC: 1606AN: 1450458Hom.: 38 Cov.: 32 AF XY: 0.00102 AC XY: 737AN XY: 721284
GnomAD4 exome
AF:
AC:
1606
AN:
1450458
Hom.:
Cov.:
32
AF XY:
AC XY:
737
AN XY:
721284
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0176 AC: 2584AN: 146452Hom.: 47 Cov.: 27 AF XY: 0.0168 AC XY: 1198AN XY: 71504
GnomAD4 genome
AF:
AC:
2584
AN:
146452
Hom.:
Cov.:
27
AF XY:
AC XY:
1198
AN XY:
71504
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Pathogenic:1Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
CIC-rearranged sarcoma Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | Children's Cancer Therapy Development Institute | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 04, 2022 | - - |
AKR1C2-related disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 05, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at